肿瘤(癌症)患者之家
首页
癌症知识
肿瘤中医药治疗
肿瘤药膳
肿瘤治疗技术
前沿资讯
登录/注册
VIP特权

文章目录

ATAC-seq在肿瘤特异性T细胞耗竭中的应用

Application of ATAC-seq in tumor-specific T cell exhaustion 

原文发布日期:2022-07-06 

英文摘要:

摘要翻译: 

原文链接:

文章:

ATAC-seq在肿瘤特异性T细胞耗竭中的应用

Application of ATAC-seq in tumor-specific T cell exhaustion 

原文发布日期:2022-07-06 

英文摘要:

Researches show that chronic viral infection and persistent antigen and/or inflammatory signal exposure in cancer causes the functional status of T cells to be altered, mainly by major changes in the epigenetic and metabolic environment, which then leads to T cell exhaustion. The discovery of the immune checkpoint pathway is an important milestone in understanding and reversing T cell exhaustion. Antibodies targeting these pathways have shown superior ability to reverse T cell exhaustion. However, there are still some limitations in immune checkpoint blocking therapy, such as the short-term nature of therapeutic effects and high individual heterogeneity. Assay for transposase-accessible chromatin with sequencing(ATAC-seq) is a method used to analyze the accessibility of whole-genome chromatin. It uses hyperactive Tn5 transposase to assess chromatin accessibility. Recently, a growing number of studies have reported that ATAC-seq can be used to characterize the dynamic changes of epigenetics in the process of T cell exhaustion. It has been determined that immune checkpoint blocking can only temporarily restore the function of exhausted T cells because of an irreversible change in the epigenetics of exhausted T cells. In this study, we review the latest developments, which provide a clearer molecular understanding of T cell exhaustion, reveal potential new therapeutic targets for persistent viral infection and cancer, and provide new insights for designing effective immunotherapy for treating cancer and chronic infection. 

摘要翻译: 

研究表明,慢性病毒感染以及癌症中持续存在的抗原和/或炎症信号暴露会导致T细胞功能状态改变,这主要源于表观遗传和代谢环境的重大变化,进而引发T细胞耗竭。免疫检查点通路的发现是理解和逆转T细胞耗竭的重要里程碑。针对这些通路的抗体已显示出卓越的逆转T细胞耗竭能力。然而免疫检查点阻断疗法仍存在局限性,例如治疗效果持续时间短及个体异质性高等问题。转座酶可及染色质测序(ATAC-seq)是一种用于分析全基因组染色质可及性的方法,其通过超活性Tn5转座酶评估染色质开放性。近期越来越多研究报道,ATAC-seq可用于表征T细胞耗竭过程中表观遗传的动态变化。研究证实,由于耗竭T细胞表观遗传的不可逆改变,免疫检查点阻断仅能暂时恢复其功能。本研究综述了最新进展,这些进展为理解T细胞耗竭提供了更清晰的分子机制认知,揭示了针对持续性病毒感染和癌症的潜在新治疗靶点,并为设计治疗癌症和慢性感染的有效免疫疗法提供了新见解。

原文链接:

Application of ATAC-seq in tumor-specific T cell exhaustion 

相关文章

文章:肿瘤抗原优先来源于黑色素瘤和非小细胞肺癌中未突变的基因组序列
文章:年龄相关的烟酰胺腺嘌呤二核苷酸下降驱动CAR-T细胞衰竭
文章:MCSP+转移创始细胞在人类黑色素瘤转移定植早期激活免疫抑制
文章:脂质纳米颗粒递送合成抗原使实体瘤对car介导的细胞毒性敏感
文章:食管癌新辅助治疗中的进化和免疫微环境动力学
文章:CHD1缺失重编程srebp2驱动的胆固醇合成,在spop突变的前列腺肿瘤中促进雄激素响应性生长和去势抵抗
文章:对TIL细胞治疗无反应的转移性非小细胞肺癌患者的T细胞和新抗原保留受损的时间序列分析
文章:策展的癌细胞图谱提供了单细胞分辨率的肿瘤的全面表征
文章:以人群为基础的胶质瘤分子景观分析在青少年和年轻人揭示胶质瘤形成的见解
文章:肿瘤细胞上的PILRα与T细胞表面蛋白CD99相互作用抑制抗肿瘤免疫

……